"Tumor subtype and other prognostic factors in breast cancer patients with brain metastases: The updated graded prognostic assessment (Breast-GPA)." by Paul W. Sperduto

Presentation

Tumor subtype and other prognostic factors in breast cancer patients with brain metastases: The updated graded prognostic assessment (Breast-GPA).

Journal of Clinical Oncology (2019)

Paul W. Sperduto, University of Minnesota
Shane Mesko, University of Texas MD Anderson Cancer Center
Daniel Cagney, Brigham and Women's Hospital
Eric Nesbit, Northwestern University
Jason Chan, University of California, San Francisco
Jessica Lee, Duke University
Will Breen, Mayo Clinic
Diana Shi, Harvard University
Hany Soliman, Princess Margaret Hospital, Mississauga, ON, Canada;
Ryan Shanley, University of Minnesota
Ashlyn S. Everett, University of Alabama at Birmingham
Laura Masucci, CHUM-Hopital Notre-Dame, Montreal, QC, Canada;
Jill Remick, University of Maryland, Baltimore
Kristin Plichta, University of Iowa Hospitals and Clinics
Supriya K. Jain, University of Colorado Boulder
Cheng-Chia Wu, Columbia University Medical Center
John Bryant, Miami cancer Institute, Miami, FL;
James B. Yu, Yale University
Toshimichi Nakano, University of Niigata, Niigata, Japan;
Minesh P. Mehta, Miami cancer Institute, Miami, FL;

Link

Disciplines

Publication Date

May 20, 2019

DOI

10.1200/jco.2019.37.15_suppl.1079

Citation Information

Paul W. Sperduto, Shane Mesko, Daniel Cagney, Eric Nesbit, et al.. "Tumor subtype and other prognostic factors in breast cancer patients with brain metastases: The updated graded prognostic assessment (Breast-GPA)." Journal of Clinical Oncology (2019)
Available at: http://works.bepress.com/minesh-mehta/382/